Unknown NA INTERVENTIONAL 3-arm NCT03686098

The Malaysian Soy and Mammographic Density Study (MiSo)

The Malaysian Soy and Mammographic Density (MiSo) Study: A Randomized, Three-arm, Controlled Clinical Trial to Investigate the Impact of Soy Isoflavone Intake on Mammographic Density as a Biomarker of Breast Cancer Risk

Sponsor: Cancer Research Malaysia

Conditions Breast Cancer Mammographic Density

Interventions Dietary soy Soy Supplement

Updated 7 times since 2018 Last updated: Jan 29, 2019 Started: Nov 19, 2018 Primary completion: Apr 30, 2020 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer and Mammographic Density, this trial is ongoing. The trial is conducted by Cancer Research Malaysia and has accumulated 7 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Mar 2022 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status

▶ Show 2 earlier versions

Feb 2019 — Sep 2020 [monthly]

Enrolling By Invitation NA
Oct 2018 — Feb 2019 [monthly]

Enrolling By Invitation NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cancer Research Malaysia
Karolinska Institutet
Subang Jaya Medical Centre
University of Nottingham Malaysia

Data source: Cancer Research Malaysia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Subang Jaya, Malaysia